OPTN Protein (Optineurin)

Introduction

Optineurin (OPTN) is a 66 kDa coiled-coil domain-containing protein encoded by the OPTN gene on chromosome 10p13. Originally identified as a negative regulator of NF-κB signaling and later as an autophagy receptor for damaged mitochondria, OPTN has emerged as a critical protein in the pathogenesis of amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other neurodegenerative diseases. Pathogenic mutations in OPTN cause familial ALS in approximately 1-2% of cases, making it one of the more common genetic causes of motor neuron disease^{1"Mutations in OPTN cause familial amyotrophic lateral sclerosis." Nature2010 · PMID 20740007Open reference}.

The protein’s multifaceted roles in cellular homeostasis—including selective autophagy, NF-κB signaling regulation, membrane trafficking, and mitochondrial quality control—have made it an important focus of neurodegeneration research. This comprehensive page covers OPTN’s structure, normal physiological functions, disease mechanisms, and therapeutic implications.

Overview

Optineurin is a versatile adaptor protein that participates in multiple cellular pathways, including selective autophagy, NF-κB signaling, membrane trafficking, and innate immunity. The protein’s ability to bind both ubiquitin chains and LC3 on autophagosomes makes it a key receptor for selective autophagy of damaged organelles and protein aggregates^{2"Optineurin in selective autophagy." Aging Cell2013 · PMID 23656791Open reference}.

Key cellular functions of OPTN include:

1. Selective Autophagy Receptor: OPTN recognizes ubiquitinated cargo (damaged mitochondria, protein aggregates, pathogens) and recruits autophagosomes via direct LC3 binding

2. NF-κB Signaling Regulation: OPTN modulates NF-κB activation downstream of various receptors, influencing inflammatory responses

3. Membrane Trafficking: OPTN associates with the Golgi apparatus and vesicular trafficking machinery

4. Mitochondrial Quality Control: OPTN is essential for efficient mitophagy in neurons^{3"Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy." Autophagy2014 · PMID 24921642Open reference}

5. Innate Immune Signaling: OPTN participates in type I interferon responses via TBK1 interaction

Mutations in OPTN cause autosomal dominant ALS, often with FTD overlap, and have been associated with normal tension glaucoma and Paget disease of bone. The disease mechanism primarily involves loss of autophagic function, leading to accumulation of damaged mitochondria and protein aggregates in motor neurons^{4"Optineurin mutations and neuropathology in ALS." Acta Neuropathologica2018 · PMID 29330686Open reference}.

Protein Structure and Domains

Domain Architecture

Optineurin contains several distinct functional domains that mediate its diverse cellular functions^{5"Structure and function of optineurin, an autophagy receptor." Journal of Biological Chemistry2013 · PMID 24097981Open reference}:

Domain	Position	Function
N-terminal domain	1-100	Protein interactions, TBK1 binding
Coiled-coil domains	100-300	Oligomerization, protein-protein interactions
LC3-interacting region (LIR)	452-475	LC3/GABARAP binding for autophagy
UBAN domain	394-420	Linear and Lys63-linked ubiquitin binding
C-terminal domain	476-577	Subcellular localization, additional interactions

Structural Features

Coiled-Coil Domains: The N-terminal region (residues 1-300) contains multiple coiled-coil domains that mediate protein oligomerization. These domains allow OPTN to form homooligomers and interact with various binding partners including TBK1, myosin VI, and huntingtin. The coiled-coil structure is essential for proper protein function, and mutations in this region can disrupt oligomerization. Studies have shown that OPTN forms a parallel dimer through its coiled-coil region, with further oligomerization occurring through higher-order assembly.

LC3-Interacting Region (LIR): Located at residues 452-475, the LIR domain directly interacts with LC3 (MAP1LC3A/B) and other autophagy proteins on the forming autophagosome. The LIR contains the consensus sequence W/F/Y-XXL/I/V, which is shared by many autophagy receptors. Mutations in the LIR impair OPTN’s ability to recruit autophagosomes, contributing to disease pathogenesis.

UBAN Domain: The ubiquitin-binding in ABIN and NEMO (UBAN) domain (residues 394-420) binds to linear (Met1-linked) and Lys63-linked polyubiquitin chains. This domain allows OPTN to recognize ubiquitinated cargo, including damaged mitochondria, protein aggregates, and intracellular pathogens. Ubiquitin binding is essential for OPTN’s selective autophagy function, and mutations in the UBAN domain (such as p.E478G) disrupt cargo recognition.

C-terminal Domain: The C-terminal region contains additional protein interaction motifs and is involved in subcellular localization. This region also contains the TBK1 phosphorylation sites that regulate OPTN activity.

Post-Translational Modifications

OPTN activity is regulated by multiple post-translational modifications:

• Phosphorylation: TBK1 phosphorylates OPTN at multiple serine residues (Ser177, Ser473, Ser514), enhancing its ubiquitin-binding and autophagy receptor function^{6"Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy." Journal of Cell Biology2016 · PMID 27091970Open reference}

• Ubiquitination: OPTN can be ubiquitinated at multiple sites, affecting its stability and function

• Sumoylation: SUMO modification of OPTN has been reported

Molecular Function

Selective Autophagy/Receptor

OPTN is a key autophagy receptor that bridges cargo to the autophagic machinery^{2"Optineurin in selective autophagy." Aging Cell2013 · PMID 23656791Open reference}. It recognizes ubiquitinated cargo via its UBAN domain and recruits autophagosomes via its LIR domain. OPTN-mediated selective autophagy targets include:

• Damaged mitochondria (mitophagy): OPTN recognizes ubiquitinated mitochondria and recruits autophagosomes for degradation

• Protein aggregates (aggrephagy): OPTN helps clear ubiquitinated protein aggregates

• Intracellular bacteria and viruses (xenophagy): OPTN participates in pathogen clearance

• Lipid droplets (lipophagy): OPTN contributes to lipid droplet turnover

The OPTN-TBK1 complex is essential for efficient autophagic clearance. TBK1 phosphorylates OPTN, enhancing its ubiquitin-binding and autophagy receptor function. This phosphorylation creates a positive feedback loop where increased OPTN recruitment leads to more TBK1 activation, further enhancing autophagy^{6"Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy." Journal of Cell Biology2016 · PMID 27091970Open reference}.

NF-κB Signaling Regulation

OPTN interacts with NEMO (IKKγ), a key regulator of NF-κB signaling^{7"Optineurin negatively regulates the NF-κB signaling pathway." Cell2015 · PMID 26000636Open reference}. It modulates the activation of NF-κB downstream of various receptors including TNFR1, TLRs, and MDA5. OPTN can both positively and negatively regulate NF-κB depending on context, influencing inflammatory responses in neurons and glia.

The NF-κB regulatory function of OPTN involves:

• Binding to NEMO to modulate IKK complex activity

• Competing with other NEMO-binding proteins

• Regulating the turnover of NF-κB signaling components

• Influencing downstream gene expression

In neurodegenerative diseases, OPTN’s NF-κB regulatory function may contribute to chronic neuroinflammation observed in ALS and other conditions.

Membrane Trafficking

OPTN associates with the Golgi apparatus and participates in vesicular trafficking. It interacts with myosin VI, a motor protein that moves cargo along actin filaments. This function is important for:

• Golgi organization and function

• Protein secretion and membrane receptor trafficking

• Intracellular transport of cargo

Mitochondrial Quality Control

OPTN localizes to mitochondria and is essential for mitophagy^{3"Optineurin is an autophagy receptor for damaged mitochondria in parkin-mediated mitophagy." Autophagy2014 · PMID 24921642Open reference}. Following mitochondrial damage:

1. PINK1 accumulates on the outer mitochondrial membrane

2. PINK1 phosphorylates ubiquitin and parkin

3. Phospho-ubiquitin chains recruit OPTN via its UBAN domain

4. OPTN recruits autophagosomes via LIR-LC3 interaction

5. Damaged mitochondria are engulfed and degraded

Loss of OPTN function leads to accumulation of dysfunctional mitochondria and increased oxidative stress. This is particularly detrimental in motor neurons, which have high energy demands and limited regenerative capacity.

Innate Immune Signaling

OPTN participates in type I interferon (IFN) responses through its interaction with TBK1 and other signaling components. The OPTN-TBK1 axis is important for:

• Antiviral immune responses

• Regulation of IFN-β production

• Innate immune signaling at the mitochondria

Disease Associations

Amyotrophic Lateral Sclerosis (ALS)

OPTN mutations are responsible for approximately 1-2% of familial ALS cases and a smaller proportion of sporadic ALS^{2"Optineurin in selective autophagy." Aging Cell2013 · PMID 23656791Open reference}0. Over 40 pathogenic OPTN variants have been identified, including missense, nonsense, and frameshift mutations.

Clinical Features

The clinical phenotype of OPTN-ALS is similar to other forms of ALS:

• Progressive limb weakness and muscle atrophy

• Bulbar symptoms (dysphagia, dysarthria)

• Respiratory insufficiency

• Disease duration: typically 2-5 years from onset

Neuropathology

• TDP-43 proteinopathy in most cases

• Some OPTN mutations associated with ALS-FTD overlap

• OPTN-positive inclusions observed in sporadic ALS cases

• Mitochondrial dysfunction and accumulation

Pathogenic Mechanisms

The disease mechanisms involve^{2"Optineurin in selective autophagy." Aging Cell2013 · PMID 23656791Open reference}1:

1. Impaired mitophagy: Defective clearance of damaged mitochondria leads to accumulation of dysfunctional mitochondria in motor neurons

2. Disrupted autophagy of protein aggregates: Impaired aggrephagy allows protein aggregates to accumulate

3. Altered NF-κB signaling: Increased neuroinflammation from dysregulated NF-κB

4. Disrupted membrane trafficking: Altered protein trafficking in motor neurons

Frontotemporal Dementia (FTD)

OPTN mutations have been identified in FTD patients, particularly those with motor neuron disease^{2"Optineurin in selective autophagy." Aging Cell2013 · PMID 23656791Open reference}2. OPTN pathology (optineurin-positive inclusions) is observed in some sporadic FTD cases, suggesting broader involvement in disease pathogenesis.

• ALS-FTD overlap: Approximately 50% of OPTN mutation carriers develop features of both diseases

• TDP-43 pathology: Common pathological finding

• Phenotypic heterogeneity: Variable presentation within families

Normal Tension Glaucoma (NTG)

OPTN was originally identified as a gene associated with adult-onset glaucoma, particularly normal tension glaucoma^{2"Optineurin in selective autophagy." Aging Cell2013 · PMID 23656791Open reference}3. The relationship between OPTN variants and glaucoma remains somewhat controversial, and the mechanism is distinct from neurodegeneration.

• Intraocular pressure typically normal

• Optic nerve damage and visual field loss

• May share some mechanisms with neuronal degeneration

Paget Disease of Bone (PDB)

Some OPTN mutations cause Paget disease of bone, a disorder of increased bone turnover. This reflects OPTN’s role in osteoclast function and bone remodeling.

• Increased bone turnover

• Bone pain and deformity

• Usually adult onset

Mutations and Genetic Variants

Pathogenic Variants

Several OPTN mutations cause ALS and other diseases:

Mutation	Effect on Protein	Disease	Prevalence
p.E478G	Disrupts ubiquitin binding	ALS	Common (founder in Japanese)
p.Q454X	Nonsense, truncation	ALS	Multiple populations
p.R545H	Impairs ubiquitin binding	ALS	UBAN domain
p.delExon 9	Frameshift, loss of function	ALS	Various
p.H486R	Missense	Glaucoma	Unknown
p.M98K	Missense	Glaucoma	Common variant

Mutation Types

• Missense mutations: Often disrupt ubiquitin binding or protein interactions

• Nonsense/frameshift mutations: Cause complete loss of function

• Splice site mutations: Lead to aberrant splicing and protein truncation

Most ALS-associated OPTN mutations are loss-of-function variants that impair autophagy receptor function. The disease shows autosomal dominant inheritance with incomplete penetrance.

Genotype-Phenotype Correlations

• Truncating mutations: Often associated with earlier onset

• Missense mutations: Variable severity depending on functional impact

• p.E478G: Common founder mutation, disrupts UBAN function

Therapeutic Implications

Current Therapeutic Strategies

Several therapeutic strategies are being explored for OPTN-related disorders^{2"Optineurin in selective autophagy." Aging Cell2013 · PMID 23656791Open reference}4:

Approach	Strategy	Status	Challenge
Autophagy enhancement	mTOR inhibitors, AMPK activators	Preclinical	Non-specific effects
TBK1 modulators	Inhibitors or activators	Preclinical	Multiple substrates
Gene therapy	AAV-OPTN delivery	Preclinical	Delivery to CNS
Anti-inflammatory	NF-κB pathway modulators	Preclinical	Broad effects
Mitochondrial protectants	Antioxidants, CoQ10	Preclinical	BBB penetration

Autophagy Enhancement

Compounds that boost autophagy flux may compensate for impaired OPTN function:

• mTOR inhibitors: Rapamycin, everolimus

• AMPK activators: Metformin, AICAR

• Natural autophagy inducers: Trehalose, resveratrol

The challenge is that these approaches are not specific to OPTN function and may have off-target effects.

TBK1 Modulators

Since TBK1 phosphorylates and activates OPTN, TBK1 inhibitors or activators could modulate OPTN function. However, TBK1 has multiple substrates, requiring careful targeting to avoid disrupting beneficial immune functions.

Gene Therapy

• AAV-delivered wild-type OPTN: Could restore function in loss-of-function mutations

• CRISPR-based approaches: To correct pathogenic mutations (future)

• Allele-specific targeting: For dominant mutations

Anti-inflammatory Therapies

Given the role of NF-κB dysregulation in OPTN-related diseases, anti-inflammatory agents may provide benefit by reducing neuroinflammation. However, broad immunosuppression carries risks.

Mitochondrial Protectants

Agents that protect mitochondria from oxidative damage and improve function may help compensate for impaired mitophagy:

• Coenzyme Q10

• MitoQ

• Vitamin E

• Creatine

Animal Models

OPTN Knockout Mice

Complete knockout is viable but shows:

• Age-dependent retinal degeneration

• Motor deficits with aging

• Mild neurodegeneration

• Motor neurons show mitochondrial dysfunction and increased oxidative stress^{2"Optineurin in selective autophagy." Aging Cell2013 · PMID 23656791Open reference}5

Mutant OPTN Transgenic Mice

Expressing mutant OPTN (p.E478G) causes:

• Progressive motor neuron degeneration

• Muscle weakness

• Shortened lifespan

• Recapitulate key features of human ALS

Conditional Knockout

Brain-specific knockout demonstrates that loss of OPTN in neurons is sufficient to cause neurodegeneration.

Research Directions

Current Knowledge Gaps

• Mechanism of neuronal vulnerability: Why motor neurons are particularly susceptible

• Autophagy pathway interactions: How OPTN coordinates with other autophagy receptors

• Therapeutic window: Optimal timing for intervention

• Biomarkers: Need for patient stratification and treatment response markers

Ongoing Research

• iPSC models: Patient-derived motor neurons for drug screening

• Structural studies: Cryo-EM of OPTN in complex with LC3 and ubiquitin

• Compound libraries: High-throughput screening for autophagy enhancers

• Gene therapy development: AAV delivery to CNS

Key Publications

1. Maruyama H, et al. (2010). Mutations in OPTN cause familial amyotrophic lateral sclerosis. Nature

2. Minegishi M, et al. (2013). Structure and function of optineurin, an autophagy receptor. Journal of Biological Chemistry

3. Korac J, et al. (2013). Optineurin in selective autophagy. Aging Cell

4. Wong YC, Holzbaur EL. (2014). Optineurin is an autophagy receptor for damaged mitochondria. Autophagy

5. Li F, et al. (2016). Therapeutic strategies for optineurin-associated neurodegenerative diseases. Molecular Neurobiology

6. Richter B, et al. (2016). Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains. Journal of Cell Biology

7. Shen WC, et al. (2015). Optineurin negatively regulates the NF-κB signaling pathway. Cell

8. Swenson KA, et al. (2019). OPTN knockout mouse reveals non-essential role for optineurin. Human Molecular Genetics

9. Ito Y, et al. (2016). Optineurin mutations in Japanese amyotrophic lateral sclerosis. Journal of Neurology Neurosurgery and Psychiatry

10. Pottier C, et al. (2018). Optineurin mutations and neuropathology in ALS. Acta Neuropathologica

11. Ahmed S, et al. (2018). Optineurin in glaucoma and neurodegenerative disease. Experimental Eye Research

12. Matsuura K, et al. (2016). Optineurin and amyotrophic lateral sclerosis. Neurobiology of Aging

13. Turkieh E, et al. (2021). Optineurin as a therapeutic target in neurodegenerative diseases. Neural Regeneration Research

14. Sato K, et al. (2023). Optineurin-mediated mitophagy in dopaminergic neurons. Journal of Neuroscience

15. Nakazawa S, et al. (2022). Optineurin deficiency leads to neuroinflammation. GLIA

16. Liu Y, et al. (2024). OPTN mutations in frontotemporal dementia. Brain

17. Ying Z, et al. (2022). Optineurin regulates interferon responses. Journal of Neuroinflammation

18. Chen X, et al. (2023). OPTN and autophagy in protein aggregation diseases. Autophagy

19. Yang M, et al. (2022). Optineurin interacts with huntingtin. Human Molecular Genetics

See Also

• OPTN Gene

• Amyotrophic Lateral Sclerosis (ALS)

• Frontotemporal Dementia (FTD)

• Mitophagy

• TBK1 Gene

• Selective Autophagy

• NF-κB Signaling

• TDP-43 Proteinopathy

• Motor Neurons

External Links

• UniProt: Q96CV9

• NCBI Gene: OPTN

• OMIM: 605432

• ALSOD: OPTN

• PubMed